These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9786361)

  • 1. FDA gets advice on Modernization Act compliance.
    Marwick C
    JAMA; 1998 Oct; 280(14):1214-5. PubMed ID: 9786361
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk.
    Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA cracks down on labeling, initiates trial result reporting.
    Osborne R; Waltz E
    Nat Biotechnol; 2008 Nov; 26(11):1203-4. PubMed ID: 18997742
    [No Abstract]   [Full Text] [Related]  

  • 4. Postmarket surveillance. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ORA's role at FDA headquarters and in the field for product recalls.
    Whetstone SN
    Food Drug Law J; 1998; 53(3):513-6. PubMed ID: 10346723
    [No Abstract]   [Full Text] [Related]  

  • 6. What you should know about FDA-USP Drug Product Problem Reporting Program.
    McGinnis DM
    Pharm Times; 1986 Apr; 52(4):101-4, 109. PubMed ID: 10276472
    [No Abstract]   [Full Text] [Related]  

  • 7. IOM panel hears concerns about U.S. drug safety system.
    Young D
    Am J Health Syst Pharm; 2005 Jul; 62(14):1428, 1430-31. PubMed ID: 15998915
    [No Abstract]   [Full Text] [Related]  

  • 8. Look-alike, sound-alike drug names.
    Jt Comm Perspect; 2001 Jul; 21(7):10-1. PubMed ID: 11467264
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse drug events and near misses: who's counting?
    Wu AW
    Am J Med; 2000 Aug; 109(2):166-8. PubMed ID: 10967161
    [No Abstract]   [Full Text] [Related]  

  • 10. Deterring inefficient pharmaceutical litigation: an economic rationale for the FDA regulatory compliance defense.
    Viscusi WK; Rowland SR; Dorfman HL; Walsh CJ
    Spec Law Dig Health Care Law; 1996 Mar; (205):9-52. PubMed ID: 10156421
    [No Abstract]   [Full Text] [Related]  

  • 11. The Safe Medical Devices Act of 1990--FDA. Notice.
    Fed Regist; 1991 Apr; 56(66):14111-3. PubMed ID: 10111151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA seeks advice on track-and-trace systems.
    Traynor K
    Am J Health Syst Pharm; 2011 Apr; 68(7):552-4. PubMed ID: 21411794
    [No Abstract]   [Full Text] [Related]  

  • 13. The FDA and new safety warnings.
    Moore TJ; Singh S; Furberg CD
    Arch Intern Med; 2012 Jan; 172(1):78-80. PubMed ID: 22232155
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-market drug safety evidence sources: an analysis of FDA drug safety communications.
    Ishiguro C; Hall M; Neyarapally GA; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2012 Oct; 21(10):1134-6. PubMed ID: 23033257
    [No Abstract]   [Full Text] [Related]  

  • 15. The Safe Medical Devices Act.
    Williams MA
    South Hosp; 1992; 58(2):16-7. PubMed ID: 10118188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical industry perspective on risk evaluation and mitigation strategies: manufacturer take heed.
    Nicholson S; Peterson J; Yektashenas B
    Expert Opin Drug Saf; 2012 Mar; 11(2):299-314. PubMed ID: 22233294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premier databases to support FDA surveillance related to drug safety.
    Health Care Strateg Manage; 2001 Nov; 19(11):10. PubMed ID: 11729600
    [No Abstract]   [Full Text] [Related]  

  • 18. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 19. "Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
    Murphy S; Roberts R
    J Allergy Clin Immunol; 2006 Jan; 117(1):34-9. PubMed ID: 16387581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of container labeling in a sample of commonly prescribed children's oral medications.
    Wallace LS; Keenum AJ; DeVoe JE
    Res Social Adm Pharm; 2010 Dec; 6(4):272-9. PubMed ID: 21111385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.